SG
Satyabrata Goswami
About Satyabrata Goswami
Data last updated:
Satyabrata Goswami is a Director at Inkas Pharmaceuticals Private Limited (since 2022). The company operates in Food And Beverages. Inkas Pharmaceuticals Private Limited reported revenue of ₹9.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Inkas Pharmaceuticals Private Limited U24303AS2022PTC022460 | Director | 19 Jan 2022 | 2022 | ₹9.7 Lakh (FY 2025) | Active |
Board colleagues of Satyabrata Goswami
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sadhana Chakroborty | 09473347 | Inkas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyabrata Goswami
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyabrata Goswami
Satyabrata Goswami currently holds 1 directorship: Inkas Pharmaceuticals Private Limited (Director, since 19 Jan 2022, revenue ₹9.7 Lakh (FY 2025)).
Satyabrata Goswami was first appointed on 19 Jan 2022 as Director at Inkas Pharmaceuticals Private Limited.
The current boards of Satyabrata Goswami's companies include Sadhana Chakroborty (Inkas Pharmaceuticals Private Limited).